Vertex, Inc. ( NASDAQ:VERX ) recently posted some strong earnings, and the market responded positively. We have ...

VertexPharma wants to transform the treatment of pain. An upcoming sciatica clinical trial readout will be pivotal.

Evercore ISI analyst Liisa Bayko maintained a Hold rating on Theravance Biopharma (TBPH – Research Report) today and set a price target ...

Vertex (VERX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

CWA, one of the largest video game unions in the United States, have gone on strike. The action involves workers in ZeniMax ...

Formula One-owner Liberty Media will sharpen its focus on its motorsports businesses by spinning off most of its other assets ...

Sigma Planning Corp trimmed its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 8.7% during the third quarter, according to its most recent disclosure with the ...

Vertex has reached a key moment because the U.S. Food and Drug Administration (FDA) is reviewing its candidate, suzetrigine, ...

Cell tower in North Hampton is eagerly awaited by many who hope it will significantly improve the numerous areas with poor ...

Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...